Last update 30 Aug 2025

Paclitaxtide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Paclitide
Target
Tubulin
Action
inhibitors
Mechanism
Tubulin inhibitors
Therapeutic Areas
NeoplasmsRespiratory DiseasesSkin and Musculoskeletal Diseases
Active Indication
Breast CancerNon-Small Cell Lung CancerAdvanced breast cancer+ [1]
Inactive Indication-
Originator Organization
Fannin Bioscience
Active Organization
Sichuan Yuansheng Biological Pharmaceutical Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with Paclitaxtide
CTR20132193
/ Active, not recruitingPhase 2
对比紫杉醇单药治疗局部晚期和/或转移性乳腺癌有效性及安全性的随机、开放、平行对照、多中心Ⅱb临床试验
[Translation] A randomized, open, parallel-controlled, multicenter Ⅱb clinical trial comparing the efficacy and safety of paclitaxel monotherapy in the treatment of locally advanced and/or metastatic breast cancer
ChiCTR-TRC-10001163
/ CompletedPhase 2
Efficacy and safety of paclitide versus paclitaxel for locally advanced and/or metastatic breast cancer: an open-label, multi-center, phase IIb, randomized controlled trial
CTR20130333
/ Active, not recruitingPhase 2
单药治疗晚期恶性肿瘤的开放、无对照、多中心的Ⅱa 期临床试验
[Translation] An open, uncontrolled, multicenter phase IIa clinical trial of monotherapy for advanced malignant tumors
100 Clinical Results associated with Paclitaxtide
Login to view more data
100 Translational Medicine associated with Paclitaxtide
Login to view more data
100 Patents (Medical) associated with Paclitaxtide
Login to view more data
100 Deals associated with Paclitaxtide
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Breast CancerPhase 3
China
Sichuan Yuansheng Biological Pharmaceutical Co., Ltd.
-
Non-Small Cell Lung CancerPhase 3
China
Sichuan Yuansheng Biological Pharmaceutical Co., Ltd.
-
Advanced breast cancerPhase 2
China
Sichuan Yuansheng Biological Pharmaceutical Co., Ltd.
17 Nov 2009
Advanced cancerPhase 2
China
Sichuan Yuansheng Biological Pharmaceutical Co., Ltd.
17 Nov 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free